Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cryoport Inc (CYRX)

Cryoport Inc (CYRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cryoport Inc 112 Westwood Place Suite 350 Brentwood TN 37027 USA

www.cryoportinc.com Employees: 1,170 P: 949-470-2300

Description:

CryoPort, Inc. operates as a provider of shipping solutions comprising cold chain frozen shipping system for transporting biological, environmental and other temperature sensitive materials at temperatures below minus 150' Celsius. Its products include CryoPort Express Shippers, cryogenic dry vapor shippers capable of maintaining cryogenic temperatures; biological material holders for the shipment of infectious or dangerous goods; CryoPort Express System to programmatically manage order entry and various aspects of shipping operations; and CryoPort Express Analytics, to monitor shipment performance metrics and to evaluate temperature-monitoring data collected by the data logger during shipment. The Company's products find their application in the transportation of live cell pharmaceutical products, such as cancer vaccines, diagnostic materials, semen and embryos, and infectious substances. CryoPort, Inc. is based in Lake Forest, California.

Key Statistics

Overview:

Market Capitalization, $K 324,762
Enterprise Value, $K 684,732
Shares Outstanding, K 49,431
Annual Sales, $ 233,260 K
Annual Net Income, $ -99,590 K
Last Quarter Sales, $ 56,660 K
Last Quarter Net Income, $ 810 K
EBIT, $ -137,240 K
EBITDA, $ -57,660 K
60-Month Beta 1.63
% of Insider Shareholders 10.10%
% of Institutional Shareholders 92.90%
Float, K 44,438
% Float 89.90%
Short Volume Ratio 0.25

Growth:

1-Year Return -51.44%
3-Year Return -90.13%
5-Year Return -58.29%
5-Year Revenue Growth 1,088.28%
5-Year Earnings Growth -354.84%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.02 on 11/07/24
Next Earnings Date N/A
Earnings Per Share ttm -1.29
EPS Growth vs. Prev Qtr 93.94%
EPS Growth vs. Prev Year 93.55%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 05/19/15

CYRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -13.35%
Return-on-Assets % -6.43%
Profit Margin % -42.69%
Debt/Equity 0.48
Price/Sales 1.47
Price/Cash Flow 17.73
Price/Book 0.89
Book Value/Share 8.47
Interest Coverage -17.06
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar